Consumer Health in Israel

Consumer Health in Israel


Consumer health is expected to see steady strong current value growth in Israel in 2024. The Israeli economy saw a large dip over the last quarter of 2023, contracting by over 20% according to the Bank of Israel. However, in line with most of 2023, the Israeli Government sought to get inflation under control and, by the end of 2023, inflation also saw a drop, to just under 3%.

Euromonitor International's Consumer Health in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Consumer Health in Israel
Euromonitor International
October 2024
List Of Contents And Tables
CONSUMER HEALTH IN ISRAEL
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
People demand more pain relief in 2024 due to stress of Israel-Hamas war
Consumers become interested in more natural variants to analgesics
A few players dominate the competitive landscape
PROSPECTS AND OPPORTUNITIES
CBD based products could see good growth over the forecast period
Old favourites likely to lead market into the future
Israel-Hamas war likely to have ongoing effect on pain relief sales
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Paediatric remedies see highest growth in volume terms over 2024
Combination products continue to do well in 2024, with rising prices boosting value sales
Teva Pharmaceutical continues to reign in 2024
PROSPECTS AND OPPORTUNITIES
Combination products continue to take lion’s share of the market
Price rises expected from 2025
No major launches expected for now
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Diarrhoeal remedies sees growth in 2024
Popularity of probiotic supplements dents sales of digestive remedies
Prices remain fairly stable over 2024, while GSK Consumer Healthcare retains lead
PROSPECTS AND OPPORTUNITIES
Retail e-commerce expected to see good penetration over the forecast period
High prevalence of bowel disorders to keep sales high
Herbal products may take sales away from standard digestive remedies
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
An ageing population promotes sales in 2024
Increasing awareness of skin health helps to boost sales
Perrigo Israel Pharmaceuticals retains lead
PROSPECTS AND OPPORTUNITIES
Price rises expected over the forecast period
A rise in skin disorders due to geopolitical issues is likely over the early forecast period
Awareness of skin health will continue to promote sales of dermatologicals.
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
A rise in smoking means a dent in NRT smoking cessation aids sales over 2024
Alternatives to NRT smoking cessation aids
Geopolitical tensions boost smoking rates in 2024
PROSPECTS AND OPPORTUNITIES
NRT smoking cessation aids likely to continue to suffer from return to smoking
NRT smoking cessation aids likely to do better when Israel-Hamas war stops
Government’s new multi-pronged action plan to combat smoking
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
A rise in anxiety due to Israel-Hamas war fuels demand for sleep aids
An ageing population also drives growth in sleep aids
Herbal sleep aids are becoming increasingly popular in 2024
PROSPECTS AND OPPORTUNITIES
Herbal sleep aids are likely to become increasingly popular
Israel-Hamas war will fuel demand for sleep aids
Rising prices may dampen potential growth
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2019-2024
Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
EYE CARE IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Increased screen exposure drives sales of standard eye care in 2024
High prevalence of dry eye syndrome in the country fuels sales of eye care
Allergy eye care remains a small market although demand is there
PROSPECTS AND OPPORTUNITIES
Lifestyle factors and increasing incidence of allergies to drive growth
Systane likely to do well as differentiation increases in importance over the forecast period
Rising interest in natural products
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2019-2024
Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
WOUND CARE IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Demand for more advanced products helps to shift value sales
Life private label continues to do well in 2024
Nexcare continues to lead wound care in 2024
PROSPECTS AND OPPORTUNITIES
Consumers likely to display demand for more product differentiation
Online channels to sell more types of survival wound kits
Innovation and interest needed to stimulate sales and tap into demand.
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Israelis increasingly demand different types of vitamins
Single vitamins and paediatric vitamins do well over 2024
Ta’am Teva-Altman General Partnership stays on top despite losing share
PROSPECTS AND OPPORTUNITIES
Online sales expected to increase over the forecast period
Herbal/traditional variants to take growth from standard products
Demand for different product formats to continue
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2019-2024
Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
DIETARY SUPPLEMENTS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Dietary supplements continue to see good growth on back of high demand
An ageing population also helps to keep sales of dietary supplements buoyant
Herbal variants drive value growth in dietary supplements in 2024
PROSPECTS AND OPPORTUNITIES
Herbal products expected to lead the way
Expanding elderly population likely to enhance sales
Rising costs may deter consumers from making purchases
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
WEIGHT MANAGEMENT AND WELLBEING IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Weight loss supplements driving market trends in 2024, while market suffers from counterfeit brands
Herbal/traditional products gain interest
Herbalife International of Israel (1990) Ltd holds on to top ranking
PROSPECTS AND OPPORTUNITIES
Market feels the squeeze with rising prices and an expected rise in VAT.
Weight loss supplements expected to be the major product over the forecast period
Ozempic banned as weight loss product in 2024.
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
SPORTS NUTRITION IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Dynamic growth in 2024
Allin remains leading brand, although other players enter the market in 2024
Protein bars increasingly consumed as snacks by people who are not engaged in sport
PROSPECTS AND OPPORTUNITIES
Import restrictions on mass protein bars prevent market entry for non-Israeli players
Sports protein powder to see growth dampened by protein bars
E-commerce and gyms are expected to see good growth over the forecast period
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
HERBAL/TRADITIONAL PRODUCTS IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Large demand for herbal/traditional products over 2024
Sleep aids performing well due to stress caused by Israel-Hamas war
Herbal/traditional paediatric dietary supplements continue to see good growth in 2024
PROSPECTS AND OPPORTUNITIES
Price increases may dampen future growth
Popular herbal/traditional products expected to do well over the forecast period
Retail e-commerce to see good sales over the forecast period
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
PAEDIATRIC CONSUMER HEALTH IN ISRAEL
KEY DATA FINDINGS
2024 DEVELOPMENTS
Paediatric vitamins continue to see buoyant sales over 2024
Herbal/traditional paediatric dietary supplements continue to see good growth
Paediatric calming products are becoming more prominent
PROSPECTS AND OPPORTUNITIES
Herbal/traditional paediatric supplements expected to see good performance
Positive outlook for paediatric heartburn and digestive remedies
Online sales expected to grow further over the forecast period
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings